Capricor Therapeutics Reports 2024 Financial Results
PremiumCompany AnnouncementsCapricor Therapeutics Reports 2024 Financial Results
17d ago
Capricor Therapeutics reports Q4 EPS (16c), consensus (9c)
Premium
The Fly
Capricor Therapeutics reports Q4 EPS (16c), consensus (9c)
17d ago
Capricor Therapeutics options imply 8.9% move in share price post-earnings
Premium
The Fly
Capricor Therapeutics options imply 8.9% move in share price post-earnings
17d ago
Capricor Therapeutics call volume above normal and directionally bullish
PremiumThe FlyCapricor Therapeutics call volume above normal and directionally bullish
1M ago
Capricor Therapeutics options imply 7.5% move in share price post-earnings
Premium
The Fly
Capricor Therapeutics options imply 7.5% move in share price post-earnings
1M ago
Target reports Q4 beat, Walgreens reportedly near go-private deal: Morning Buzz
Premium
The Fly
Target reports Q4 beat, Walgreens reportedly near go-private deal: Morning Buzz
1M ago
Capricor Therapeutics options imply 31.0% move in share price post-earnings
PremiumThe FlyCapricor Therapeutics options imply 31.0% move in share price post-earnings
1M ago
Capricor completes BLA on time, requests priority review, says H.C. Wainwright
Premium
The Fly
Capricor completes BLA on time, requests priority review, says H.C. Wainwright
3M ago
Capricor Therapeutics completes submission of BLA to FDA for deramiocel
Premium
The Fly
Capricor Therapeutics completes submission of BLA to FDA for deramiocel
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100